Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-31 · accession 0001773751-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-01 | 2023-01-31 | HIMS | Boughton Soleil | CLO | S - Sale | $8.14 | -50.0K | 237.1K | -17% | -$407.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-31 | S | D | 50,000 | $8.14 | 237,089 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2022 by the Reporting Person. (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.00 - $8.28. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |